Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q2 FY2027 Earnings Presentation
23 slides from Clean Science & Technology's earnings presentation, Oct 31, 2026
Slide 1: Exchange filing cover letter
31st October, 2026 To BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai – 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543318 Trading Symbol: CLEAN Subject: Investor Presentation
Slide 2: Clean Science and Technology Ltd. Investor Presentation Q2 FY2027
Clean Science and Technology Ltd. Investor Presentation Q2 FY 2027 I October 2026
Slide 3: Safe Harbour
SAFE HARBOUR This investor presentation has been prepared by Clean Science and Technology Limited (“CSTL”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered o
Slide 4: Q2 FY2027 Business Update
Q2 FY 2027 Business Update
Slide 5: Q2 FY2027 Update - Consolidated
Q2 FY2027 UPDATE - Consolidated Progressive revenue growth supported by new segment, margins moderated due to geopolitical headwinds Revenue in INR Crore 241 264 243 245 220 249 268 299 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Q2 FY27 41.5% 40.9% 41.6% 43.3% 40.1% 39.9% 38.9% 39.7% 37
Slide 6: Q2 FY2027 P&L Overview
Q2 FY2027 P&L OVERVIEW Core business strong, new business scaling: CFCL adds INR ~48 crs of YoY sales and turns PAT positive P&L (INR Crore) STANDALONE CONSOLIDATED Particular Q2 FY2027 Q1 FY2027 Q-o-Q (%) Q2 FY2026 Y-o-Y (%) Q2 FY2027 Q1 FY2026 Q-o-Q (%) Q2 FY2026 Y-o-Y (%) Sale of products 226 203
Slide 7: H1 FY2027 P&L Overview
H1 FY2027 P&L OVERVIEW Stronger growth coming from newer segments, contributing to 22% of the revenue during the first half of the year P&L (INR Crore) STANDALONE CONSOLIDATED Particular H1FY2027 H1FY2026 Y-o-Y (%) H1 FY2027 H1 FY2026 Y-o-Y (%) Sale of products 430 423 2% 559 480 17% Other operating
Slide 8: H1 FY2027 Balance Sheet Overview
H1 FY2027 BALANCE SHEET OVERVIEW Balance sheet shifting from investment phase to asset monitisation phase Standalone Balance Sheet As at As at Consolidated Balance Sheet As at As at (INR Crore) 30-Sept.-2026 31-March-2026 (INR Crore) 30-Sept.-2026 31-March-2026 Assets Assets Non-current assets Non-c
Slide 9: Revenue Profile - H1 FY2027 - Consolidated
REVENUE PROFILE –H1 FY 2027 - Consolidated Performance segment share increased led by higher volume of HALS series REVENUE MIX BY SEGMENT 7% 9% 13% 16% H1 FY’27 H1 FY’26 79% 75% Performance chemicals Pharma & Agro FMCG chemicals Intermediates ➢ HALS segment grew 2x during the H1 FY27 on the bank of
Slide 10: Corporate presentation
Corporate presentation
Slide 11: Clean Science and Technology at a Glance
CLEAN SCIENCE AND TECHNOLOGY AT A GLANCE A brief Introduction about the Company ➢ One of the fastest growing and among the most profitable fine and specialty chemical companies globally. Among the largest manufacturers of certain specialty chemicals developed in-house. ➢ Among the few global organiz
Slide 12: Company Evolution
COMPANY EVOLUTION Continuous R&D and Innovation has led to new product launches on a consistent basis YEAR 2009 2011 2014 2018 2020 2021 2022 2023 2024 2025 2026 REVENUES 685 936 789 957 (INR Crore) 1 19 120 241 419 512 967 ➢ Commercialized largest plant for Genesis: HALS from India 2025 2026 ➢ Tech
Slide 13: Diversified Product Profile Serving Critical End-User Industries
DIVERSIFIED PRODUCT PROFILE SERVING CRITICAL END-USER INDUSTRIES Largest capacity in the world for our flagship products PERFORMANCE PHARMA AND AGRO FMCG CHEMICALS INTERMEDIATES CHEMICALS MEHQ (Monomethyl Ether of Hydroquinone) Guaiacol 4-MAP (4-Methoxy Acetophenone) ➢ Used as polymerization inhibit
Slide 14: Key Differentiators That Add Value
KEY DIFFERENTIATORS THAT ADD VALUE Unique benefits that set our business apart from competition INNOVATION GLOBAL LEADERS PREFERRED PARTNER STATE-OF-THE-ART Strategic process innovation Among the largest OF CHOICE Multiple, automated and new product producers globally of Strong and long term manufac
Slide 15: Steadfast Focus on Research & Development
STEADFAST FOCUS ON RESEARCH & DEVELOPMENT Pioneered commercialization of catalytic reactions Research and Development team’s focus areas Enhance our existing catalyst Develop products with high demand Expand product portfolio in the 1 systems to further optimize yield 2 performance chemical segment
Slide 16: Cohesive and Technocrat Promoters
COHESIVE AND TECHNOCRAT PROMOTERS Strong visibility on longevity of Promoters’ engagement in the business Over 3 decades of work experience in Over 2 decades of experience in the the chemical industry. chemical industry. Bachelor of Chemical Technology – Bachelor of Chemical Engineering – Institute
Slide 17: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market participants underscore sound governance PROFILE OF DIRECTORS ON THE BOARD PRADEEP RATHI KEVAL DOSHI Mr. Raj Kamal Chairman and Non-Executive Non-Executive, Independent Director Non-Executive, Independent Direc
Slide 18: Continued Commitment Towards Sustainability and ESG
CONTINUED COMMITMENT TOWARDS SUSTAINABILITY AND ESG Sustainability and ESG initiatives are embedded in our long term growth strategy ENVIRONMENT EMPATHY (E) SOCIAL RESPONSIBILITY (S) CORPORATE GOVERNANCE (G) ➢ Utilize resources efficiently, reduce waste and minimize emissions as part of our ➢ Total
Slide 19: Advanced Manufacturing Facilities Designed by In-House Engineering Team
ADVANCED MANUFACTURING FACILITIES DESIGNED BY IN-HOUSE ENGINEERING TEAM 3 independent functional units under CSTL at Kurkumbh Industrial Area, Maharashtra with dedicated lines for each product UNIT 1 NO plant closure notice received from pollution 7 plants control board Total area – 30,000 sq.m All
Slide 20: Commercialized Largest Facility for HALS from India
COMMERCIALIZED LARGEST FACILITY FOR HALS FROM INDIA Largest facility of Clean Science Group housed in its wholly owned subsidiary, Clean Fino Chem Ltd. at Kurkumbh Industrial Area, Maharashtra UNIT 4 Commercialized in March 2024 Total area – 1,32,700 sq.mtrs. (34 acres) Cost advantage - Tax incentiv
Slide 21: Strong Financial Performance
STRONG FINANCIAL PERFORMANCE Resilient profitability metric across business cycle REVENUE EBITDA & EBITDA% PAT & PAT% 685 936 789 922 815 300 403 337 399 353 229 304 248 292 251 44% 34% 43% 44% 33% 43% 44% 32% 32% 32% FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY
Slide 22: Our Key Growth Drivers
KEY GROWTH LEVERS Strategic initiatives and investments aimed at long term sustainable growth FOCUS ON ESG AND SIGNIFICANT SUSTAINABILITY GREENFIELD CAPEX Capitalise on our core philosophy Planned capex on track for of clean and green chemistry to commercialising new series of address opportunities
Slide 23: Thank You
THANK YOU For further information, please contact: PRATIK BORA Email: [email protected] Clean Science and Technology Limited Website: https://www.cleanscience.co.in/
Clean Science and Technology — Q2 FY2027 Earnings Presentation on 6ix